FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204065514> ?p ?o ?g. }

• W3204065514 abstract "Abstract As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for highly potent monoclonal antibodies (mAbs) that are resistant against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VoCs). Here, we evaluate the potency of a previously described mAb J08 against these variants using cell-based assays and delve into the molecular details of the binding interaction using cryo-EM. We show that mAb J08 has low nanomolar affinity against VoCs, binds high on the receptor binding domain (RBD) ridge and is therefore unaffected by most mutations, and can bind in the RBD-up and -down conformations. These findings further validate the phase II/III human clinical trial underway using mAb J08 as a monoclonal therapy. One Sentence Summary Potent neutralizing monoclonal antibody J08 binds SARS-CoV-2 spike independent of known escape mutations." @default.
• W3204065514 created "2021-10-11" @default.
• W3204065514 creator A5001887891 @default.
• W3204065514 creator A5006754438 @default.
• W3204065514 creator A5010315360 @default.
• W3204065514 creator A5011419880 @default.
• W3204065514 creator A5015229803 @default.
• W3204065514 creator A5020444195 @default.
• W3204065514 creator A5033376690 @default.
• W3204065514 creator A5034183976 @default.
• W3204065514 creator A5036808227 @default.
• W3204065514 creator A5042447844 @default.
• W3204065514 creator A5044251474 @default.
• W3204065514 creator A5045933405 @default.
• W3204065514 creator A5046934232 @default.
• W3204065514 creator A5055664477 @default.
• W3204065514 creator A5064775398 @default.
• W3204065514 creator A5065401344 @default.
• W3204065514 creator A5067790213 @default.
• W3204065514 creator A5071641744 @default.
• W3204065514 creator A5071739282 @default.
• W3204065514 creator A5076759538 @default.
• W3204065514 creator A5078728203 @default.
• W3204065514 creator A5081970233 @default.
• W3204065514 creator A5086124703 @default.
• W3204065514 date "2021-09-29" @default.
• W3204065514 modified "2023-09-26" @default.
• W3204065514 title "Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody" @default.
• W3204065514 cites W3025744748 @default.
• W3204065514 cites W3042323010 @default.
• W3204065514 cites W3044660350 @default.
• W3204065514 cites W3045149055 @default.
• W3204065514 cites W3085153423 @default.
• W3204065514 cites W3087924281 @default.
• W3204065514 cites W3092501606 @default.
• W3204065514 cites W3111431752 @default.
• W3204065514 cites W3125712166 @default.
• W3204065514 cites W3131871667 @default.
• W3204065514 cites W3133980772 @default.
• W3204065514 cites W3138734145 @default.
• W3204065514 cites W3139074260 @default.
• W3204065514 cites W3149428818 @default.
• W3204065514 cites W3153636933 @default.
• W3204065514 cites W3155578042 @default.
• W3204065514 cites W3156343712 @default.
• W3204065514 cites W3160471157 @default.
• W3204065514 cites W3160918102 @default.
• W3204065514 cites W3162978651 @default.
• W3204065514 cites W3164250739 @default.
• W3204065514 cites W3172812363 @default.
• W3204065514 cites W3173241791 @default.
• W3204065514 cites W3185488876 @default.
• W3204065514 doi "https://doi.org/10.1101/2021.09.28.462234" @default.
• W3204065514 hasPublicationYear "2021" @default.
• W3204065514 type Work @default.
• W3204065514 sameAs 3204065514 @default.
• W3204065514 citedByCount "1" @default.
• W3204065514 countsByYear W32040655142022 @default.
• W3204065514 crossrefType "posted-content" @default.
• W3204065514 hasAuthorship W3204065514A5001887891 @default.
• W3204065514 hasAuthorship W3204065514A5006754438 @default.
• W3204065514 hasAuthorship W3204065514A5010315360 @default.
• W3204065514 hasAuthorship W3204065514A5011419880 @default.
• W3204065514 hasAuthorship W3204065514A5015229803 @default.
• W3204065514 hasAuthorship W3204065514A5020444195 @default.
• W3204065514 hasAuthorship W3204065514A5033376690 @default.
• W3204065514 hasAuthorship W3204065514A5034183976 @default.
• W3204065514 hasAuthorship W3204065514A5036808227 @default.
• W3204065514 hasAuthorship W3204065514A5042447844 @default.
• W3204065514 hasAuthorship W3204065514A5044251474 @default.
• W3204065514 hasAuthorship W3204065514A5045933405 @default.
• W3204065514 hasAuthorship W3204065514A5046934232 @default.
• W3204065514 hasAuthorship W3204065514A5055664477 @default.
• W3204065514 hasAuthorship W3204065514A5064775398 @default.
• W3204065514 hasAuthorship W3204065514A5065401344 @default.
• W3204065514 hasAuthorship W3204065514A5067790213 @default.
• W3204065514 hasAuthorship W3204065514A5071641744 @default.
• W3204065514 hasAuthorship W3204065514A5071739282 @default.
• W3204065514 hasAuthorship W3204065514A5076759538 @default.
• W3204065514 hasAuthorship W3204065514A5078728203 @default.
• W3204065514 hasAuthorship W3204065514A5081970233 @default.
• W3204065514 hasAuthorship W3204065514A5086124703 @default.
• W3204065514 hasBestOaLocation W32040655141 @default.
• W3204065514 hasConcept C142724271 @default.
• W3204065514 hasConcept C153911025 @default.
• W3204065514 hasConcept C159047783 @default.
• W3204065514 hasConcept C159654299 @default.
• W3204065514 hasConcept C163864487 @default.
• W3204065514 hasConcept C185592680 @default.
• W3204065514 hasConcept C203014093 @default.
• W3204065514 hasConcept C2777648638 @default.
• W3204065514 hasConcept C2779134260 @default.
• W3204065514 hasConcept C3007834351 @default.
• W3204065514 hasConcept C3008058167 @default.
• W3204065514 hasConcept C524204448 @default.
• W3204065514 hasConcept C542903549 @default.
• W3204065514 hasConcept C71924100 @default.
• W3204065514 hasConcept C86803240 @default.
• W3204065514 hasConceptScore W3204065514C142724271 @default.
• W3204065514 hasConceptScore W3204065514C153911025 @default.

• next